Description

Topotecan Hydrochloride*-A topoismerase I antagonist. Topotecan Hydrochloride, with a strong antineoplastic activity and a wide anticancer spectrum, is the best therapy for ovarian cancer and is also clinically involved in therapy for breast carcinoma, rectal cancer, colon carcinoma and acute or chronic leukemia. Topotecan Hydrochloride produced in CREDIT CHEMWERTH, with an assay content of NLT *9.5% and single largest impurity of NMT 0.1%, is anticipating for FDA’s inspection for cGMP compliance, and CREDIT CHEMWRTH already had whose DMF filed.